Test Price
2,800 AED✅ Home Collection Available
ADCY5 Gene Dyskinesia, Familial, with Facial Myokymia Genetic Test in UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited laboratory (Cert. INT/EGQ/2509DA/3139).
- Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain home collection available daily 8 AM–11 PM.
- Clinical Guidance: Post-test telephone consultation with a specialist for result interpretation and clinical correlation.
- Insurance Verification: Instant coverage check via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ADCY5 Gene Dyskinesia, Familial, with Facial Myokymia Genetic Test is a targeted next-generation sequencing (NGS) assay that analyzes the entire coding region of the ADCY5 gene to detect disease-causing variants. This test confirms the diagnosis of familial dyskinesia with facial myokymia, a rare movement disorder, with >99.9% accuracy. It is conducted under strict quality standards at our Dubai Healthcare City laboratory.
| Feature | DNA Labs UAE (Our Test) | Closest Alternative |
|---|---|---|
| Precision | Full-gene NGS with 99.9% sensitivity | Targeted panels or Sanger sequencing, >95% sensitivity |
| Method | NGS (Next Generation Sequencing) – advanced, validated | Limited-gene PCR or exome-wide filtering |
| Turnaround Time | 3–4 Weeks | 4–8 Weeks (often without ISO-accredited logistics) |
Pre-Test Requirements
- Provide a detailed clinical history, including age of onset and specific movement symptoms.
- Attend a mandatory genetic counselling session to construct a pedigree chart of family members affected with ADCY5-related dyskinesia.
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics licensed by the Dubai Health Authority (DHA #9294403), I emphasize that this test must always be interpreted within the full clinical context; a negative result does not exclude other movement disorders, and a positive result confirms a lifelong condition that requires multidisciplinary management.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics
Advisory: Medication Precautions
Do not discontinue any prescribed anti-epileptic or dopamine-modulating therapy without consulting your physician. Abrupt withdrawal may trigger acute dystonic exacerbation or respiratory compromise. Always discuss medication changes with your treating neurologist before the test.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active untreated systemic infection or fever within 48 hours; recent (<2 weeks) blood transfusion that may affect DNA purity.
- Red Flag – Emergency: Sudden severe dystonic storm, new-onset breathing difficulty, or loss of consciousness. Seek immediate hospital care.
- Patients under 18 years require consent and presence of a legal guardian during sample collection as per UAE medical liability law.
Patient FAQ & Clinical Guidance
1. What is the ADCY5 Gene Dyskinesia, Familial, with Facial Myokymia Genetic Test?
This NGS test identifies pathogenic variants in the ADCY5 gene, confirming the diagnosis of familial dyskinesia with facial myokymia with >99.9% accuracy. It is essential for distinguishing this rare disorder from other movement abnormalities.
2. How long does it take to receive results?
Results are typically ready within 3 to 4 weeks, ensuring thorough sequencing, bioinformatic analysis, and expert clinical interpretation for accuracy.
3. What preparations are required before the blood draw?
No fasting is required. However, a pre-genetic counselling session is strongly recommended to document family history and inform clinical correlation. Please bring any prior neurological reports and a list of current medications.
4. Can the test be performed at home?
Yes, for peripheral whole blood collection, our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM. A certified phlebotomist will visit your residence, ensuring sterile, cold-chain transport of the sample to our laboratory.
5. Will my insurance cover the test?
Coverage varies by plan. Send your insurance card via WhatsApp to +971 54 548 8731 for a pre-test eligibility check. Our team will confirm the amount covered and any required approvals.
UAE Regulatory & Data Privacy Adherence
- All testing procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields.
- Patient safety and consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Laboratory accredited under ISO 9001:2015 (Cert. INT/EGQ/2509DA/3139). DHA Facility License: 1143.
- Data transmission and storage are encrypted; results are shared only with the ordering physician and the patient.
Clinical & Logistical Metadata
| Test Name | ADCY5 Gene Dyskinesia, Familial, with Facial Myokymia Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) – or saliva upon request for home collection |
| Methodology Used | Next Generation Sequencing (NGS) – targeted ADCY5 gene coding region analysis |
| ICD-10-CM Code | G25.89 (Other specified extrapyramidal and movement disorders) |
| LOINC Code | 83429-6 (ADCY5 gene analysis in blood or tissue by sequencing) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians